Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Linoleic acid

Generic Name: Linoleic acid

Drug Type: Small Molecule

Chemical Formula: C_₁₈H_₃₂O_₂

CAS Number: 60-33-3

Unique Ingredient Identifier: 9KJL21T0QJ

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

Acne
Dermatitis
Dry Skin

Clinical Trials

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)

Phase 2

Active, not recruiting

Posted: 2025/03/25

Sponsor:ViiV Healthcare

ID:NCT06741397

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra Long-acting (CAB ULA) Following Switch From Cabotegravir Long-acting (CAB LA) in Healthy Adults

Phase 1

Recruiting

Posted: 2025/01/22

Sponsor:ViiV Healthcare

ID:NCT06786520

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Phase 3

Recruiting

Posted: 2024/11/19

Sponsor:ViiV Healthcare

ID:NCT06694805

CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

Phase 1

Not yet recruiting

Posted: 2024/03/28

Sponsor:National Institute o...

ID:NCT06336434

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Phase 3

Recruiting

Posted: 2023/11/18

Sponsor:ViiV Healthcare

ID:NCT06134362

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy